Search Results
Results found for "Affiong Ika Oqua"
- Do You Believe AI Could Accelerate Drug Discovery?
They found that AF2 models achieved accurate side-chain predictions and successfully docked high-affinity The highest affinity compounds (15 to 24 nM) were identified from AF2 docking.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
This week’s edition links ligand mechanism to the decisions that shape affinity, efficacy, selectivity focuse on the distinction between orthosteric and allosteric mechanisms and the impact of this choice on affinity Win on kinetics, not just Kd: Dynamic binding means “affinity” moves—design readouts and decisions that
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
Key results: Eight additional MQs were identified with nanomolar affinities for the V2R, all antagonists The variant MQ1-K39A showed a higher affinity for the hV2R, but not for the rat V2R.
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
have been identified to exist in at least two distinct states: an active state characterized by high affinity for agonists when coupled to G proteins, and an inactive state in which their affinity for agonists discovery of allosteric modulators for GPCRs which possess the capability to modulate and fine-tune the affinity
- Nanobodies: New Dimensions in GPCR Signaling Research
Nb6B9: This is an affinity-matured nanobody derived from Nb80. Nb9-8: This nanobody was identified for the M2 muscarinic receptor (M2R) and increased the affinity of Nb39: This nanobody was identified for the μ-opioid receptor (μOR) and also increased the affinity of
- Quantifying Receptor Selectivity in Modern Drug Discovery
But raw potency differences are not pure reflections of affinity or efficacy. What remains reflects differences in: Affinity Efficacy And importantly, this value becomes portable.
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
This also improves detection of low affinity or slow binding ligands. GPCR biology with advanced fluorescence chemistry, Celtarys custom-developed ligands offer both high affinity
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
allosteric behavior, stress-test assumptions through fit→predict→test loops, and improve SAR by separating affinity Unlock real SAR: Deconvolute potency into affinity vs. efficacy to make medicinal chemistry cycles more
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
These studies also show that disrupting the dimerization of GLP-1R results in decreased high-affinity dimerized SecR receptors exhibit higher rates of G protein activation and release, improving both binding affinity
- Targeting Intracellular Allosteric Sites in GPCRs
discovery of allosteric modulators for GPCRs which possess the capability to modulate and fine-tune the affinity classified as positive allosteric modulators (PAMs), which increase the receptor functional and/or affinity modulators targeting GPCRs can display one or more of the following pharmacological characteristics: 1) affinity
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
chemistry platform enables rapid generation of conjugates, such as labeled ligands, with excellent affinity
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
The Tissue Penetration Trap Here’s a paradox: high-affinity, slow-offset compounds can undermine their The best drug hunters learn to tune kinetic parameters strategically—not just chase the highest affinity
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
Hidden Lever in GPCR Research In GPCR pharmacology, the conversation often centers on ligand properties—affinity technical deep-dives—it teases apart practical insights by asking: How can you distinguish between a high-affinity
- Advantages of Fluorescent Probes in GPCR Assays
over other methods Fluorescent ligands are made by choosing an adequate pharmacophore with the desired affinity decrease in fluorescence as the concentration of the competitor is increased is the one used to obtain an affinity
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
idiopathic pulmonary fibrosis are currently ongoing using ligands with differing levels of selectivity and affinity
- Pharmacology at Your Fingertips: Terry’s Corner Launches
With nanomolar affinity, high specificity, and a strong signal-to-noise profile, this non-radioactive
- Endogenous ligand recognition and structural transition of a human PTH receptor
PTH-bound and PTHrP-bound structures reveals distinct ligand-receptor interactions underlying the ligand affinity
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
CELT-419 Powers D3R Binding Assays Across Platforms Celtarys Research presents CELT-419, a nanomolar-affinity
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
The directed evolution of ligand specificity in a GPCR and the unequal contributions of efficacy and affinity Extracellular loop 2 of the adenosine A1 receptor has a key role in orthosteric ligand affinity and agonist
- Endogenous ligand recognition and structural transition of a human PTH receptor
PTH-bound and PTHrP-bound structures reveals distinct ligand-receptor interactions underlying the ligand affinity
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
High-affinity agonists reveal recognition motifs for the MRGPRD GPCR Chunyu Wang , Yongfeng Liu , Marion Beyond the classic GPCR: unraveling the role of GPR155 role in cholesterol sensing and signaling High-affinity
- The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane
Affinity proteomics revealed that in the interactome of VLGR1, molecules are enriched that are associated
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
Specifically, we find the PI(4,5)P2 lipids to have a higher affinity toward the inactive conformation
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
allosterically stabilize the critical residues in the ligand-binding pocket of GPR97 and increase the affinity
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
biosensor in membrane preparations and found that observed potency values better correlated with binding affinity
- Glyco-sulfo hotspots in the chemokine receptor system
the negatively charged aminoacids and post-translational modifications (PTMs), contribute to the high affinity PTM has been shown to be heterogeneous [Li X et al. 2018; Scurci I et al. 2021) and to improve the affinity It has been also reported that PSGL-1 glycosulfo peptide analogue GSnP-6 displays nanomolar affinity
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
times, which is a measure of drug efficacy in vivo, and simultaneously assessing computational binding affinities
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
genomically related transmembrane receptors, like C5aR1 (CD88, C5aR) and C5aR2 (GPR77, C5L2) with comparable affinity
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
cells, we discovered a 4-aminopyrimidine analogue as a new intracellular CCR9 antagonist with improved affinity
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
competition with the CB 2 -selective partial agonist GW40583 is studied (left) to measure competitor binding affinity For cannabinoid researchers, this capability supports: Accurate CB2 affinity determination Visualization














